[Pharmaco-cellular enzymology of the mechanism of action of stiripentol in cardiazol-induced epilepsy. III. Protein, nucleoprotein, lipid, and proteoglycan metabolism].
D015094:3-Hydroxyacyl CoA Dehydrogenases / Q000378:metabolism; D000612:4-Aminobutyrate Transaminase / Q000037:antagonists & inhibitors; D000818:Animals; D000927:Anticonvulsants / Q000494:pharmacology* / Q000627:therapeutic use; D001192:Arylsulfatases / Q000037:antagonists & inhibitors; D001921:Brain / Q000201:enzymology; D001923:Brain Chemistry / Q000187:drug effects*; D004148:Dioxolanes / Q000494:pharmacology* / Q000627:therapeutic use; D004827:Epilepsy / Q000139:chemically induced / Q000378:metabolism* / Q000517:prevention & control; D005260:Female; D050356:Lipid Metabolism; D008297:Male; D009419:Nerve Tissue Proteins / Q000378:metabolism*; D009698:Nucleoproteins / Q000378:metabolism; D010433:Pentylenetetrazole / Q000633:toxicity; D011509:Proteoglycans / Q000378:metabolism*; D051381:Rats; D011919:Rats, Inbred Strains; D012995:Solubility
D000927:Anticonvulsants; D004148:Dioxolanes; D009419:Nerve Tissue Proteins; D009698:Nucleoproteins; D011509:Proteoglycans; D015094:3-Hydroxyacyl CoA Dehydrogenases; C021388:3-hydroxybutyryl-CoA dehydrogenase; D000612:4-Aminobutyrate Transaminase; D001192:Arylsulfatases; C021092:stiripentol; D010433:Pentylenetetrazole
Enzymologie pharmaco-cellulaire du mode d'action du Stiripentol au cours de l'épilepsie cardiazolique--III. Les métabolismes protidique, nucléoprotidique, lipidique et des protéoglycanes.